TIGIT and acute myeloid leukemia: Additionally, changes in the levels of other IC receptors have been observed on NK cells in AML patients, notably higher coexpression of TIGIT and PVRIG on CD56dimCD16+ cells, as well as the up-regulation of NKG2A expression [39,162].